Gauruv Bose
@Gauruv
Followers
184
Following
376
Media
2
Statuses
113
MS Neurologist @OttawaHospital | Assistant Professor @uOttawaMed | Associate Scientist OHRI | Fellowship @MassGenBrigham @HarvardMed
Ottawa, Canada
Joined November 2010
RT @weinerlabhms: Received the GIANTS OF MS AWARD in Research, a lifetime achievement award. Hard to believe the years have passed, but sti….
dropbox.com
Shared with Dropbox
0
6
0
RT @KlausSchmierer: New #MS diagnostic criteria for #MultipleSclerosis #MENACTRIMS #AbuDhabi2023, presented by Prof Bassem Yammout 1/8.
0
82
0
RT @NegarMowlazadeh: Check out our new paper on Progression Independent of Relapse Activity (PIRA) in NMOSD, MOGAD and MS! .Special thanks….
0
12
0
RT @MSJ_Research: Can we predict contrast+ lesions in #MultipleSclerosis using serum neurofilament #NfL? Best performance in <50 years, for….
journals.sagepub.com
Background: Contrast-enhancing magnetic resonance imaging (MRI) lesions (CELs) indicate acute multiple sclerosis inflammation. Serum biomarkers, neurofilament l...
0
5
0
RT @IJMSCtweets: What would make an #ideal #biomarker ? . Combining biomarkers as an approach?. Dr. Gauruv Bose of #Ottawa @Gauruv @ahmedzo….
0
1
0
RT @drbarrysinger: A Paralyzed Man Can Walk Naturally Again With Brain and Spine Implants Fascinating and Encourag….
0
8
0
RT @OttawaHospital: New scientist alert! Dr. @Gauruv Bose aims to use AI and #BigData to predict the course of #MultipleSclerosis. https:/….
0
7
0
RT @phil_bilodeau: Why has no one thought of opening a bar near a hospital and calling it PubMed.
0
3K
0
RT @NegarMowlazadeh: Our latest paper from @MGHNeurology is now online on @MSJ_Research! Thansk to my mentor @mlevy18 and my colleagues @Ga….
journals.sagepub.com
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has various similarities with AQP4-IgG-seropositive Neuromyelitis Optica Spec...
0
2
0
RT @NegarMowlazadeh: Today we said goodbye to Dr. @Gauruv Bose, our neuroimmunology clinical fellow in @MassGenBrigham! He is not only a gr….
0
3
0
Impressive study from @BrighamWomens @bmj_latest : double blind #RCT of over 25000 people showing #VitaminD 2000iu daily reduced #autoimmune diseases by 22% over 5 years, not bad for a safe vitamin that many are deficient in! #VITAL.
bmj.com
Objective To investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk. Design Vitamin D and omega 3 trial (VITAL), a nationwide, randomized,...
1
3
11
RT @NatRevNeurol: High or increasing serum NfL is predictive of impending multiple sclerosis relapses
0
5
0
Well deserved appointment and great for @BWHNeurology! Dr. Chitnis is also the director of the #CLIMBStudy and PI for #Foralumab Phase-1b for #MultipleSclerosis, and #Protollin Phase-1 for #AlzheimersDisease — also a fantastic mentor & fellowship director, congratulations!.
Tanuja Chitnis, M.D. has been named the department’s first Associate Chair for Clinical Trials. Dr. Chitnis is the Cindy Larsen Chugg Distinguished Chair in Neurology at BWH and Professor of Neurology, Harvard Medical School. Congratulations, Tanuja!. #BWHNeurology #BWH
0
0
4
This is it- 10 million adults, 20y follow-up. 801 dx w/MS VS 1500+ controls: EBV seroconversion occurred in ALL who developed MS, except 1. We have the target—let’s fund the treatment! @ScienceMagazine @HarvardChanSPH @mssociety @MSSocietyCanada .
0
0
0
RT @BBCWorld: Man gets genetically-modified pig heart in world-first transplant
bbc.com
David Bennett, 57, is doing well three days after the experimental surgery, doctors say.
0
437
0
RT @OnlyInBOS: Brigham and Women’s Hospital is set to begin a clinical trial that will test the safety and efficacy of a new vaccine delive….
0
193
0
RT @PamelaKanellis: Learn more about the Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo), whic….
bmcneurol.biomedcentral.com
Background Neurological disability progression occurs across the spectrum of people living with multiple sclerosis (MS). Although there are a handful of disease-modifying treatments approved for use...
0
5
0
RT @MSactivist: Thank you @POTUS for highlighting the struggles many people living with MS face when it comes to accessing the medications….
0
24
0